Market Overview:
The global structural heart disease treatment devices market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of structural heart diseases, technological advancements in treatment devices, and rising demand for minimally invasive procedures. The global structural heart disease treatment devices market is segmented by type into repair devices and replacement devices. The repair device segment is expected to grow at a higher CAGR than the replacement device segment during the forecast period. This can be attributed to the increasing use of repair devices for treating various types of structural heart diseases, such as mitral regurgitation and aortic stenosis. The global structural heart disease treatment Devices market is also segmented by application into hospitals, ambulatory surgery centers (ASCs), and others (including research institutes and academic medical centers). The hospitals segment accounted for the largest share of the global Structural Heart Disease Treatment Devices Market in 2017 owing to increased use of these treatments in hospital settings across all regions studied.
Product Definition:
Structural heart disease treatment devices are used to treat heart conditions that affect the structure of the heart. These devices include stents, valves, and pumps. The use of these devices helps to improve blood flow and cardiac function.
Repair Devices:
The global repair devices, it's usage and growth factor in structural heart disease treatment market size was valued at USD 6.5 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period.
Replacement Devices:
The replacement devices and it's usage in structural heart disease treatment market is expected to grow at a lucrative rate during the forecast period. The growth of this market can be attributed to factors such as increasing prevalence of Structural Heart Disease (SHD) coupled with rising geriatric population base, which is highly susceptible to SHD. Moreover, growing awareness levels amongst patients & general public pertaining to advanced technologies for treating SHDs are some other key drivers for this market.
Application Insights:
The others application segment held the largest share of more than 50.0% in 2017. The other applications include cardiac rehabilitation centers, home healthcare, and urgent care centers. These facilities are established outside of hospitals and offer a wide range of services for heart disease treatment including structural heart surgery, diagnostic testing, and medication management.
The hospital application segment is expected to witness the fastest growth rate over the forecast period owing to increasing awareness about available treatments for different types of structural heart diseases coupled with rising prevalence rates across various regions worldwide.
Regional Analysis:
Europe dominated the global market in 2017 owing to a high prevalence of structural heart diseases and favorable reimbursement policies. The region is expected to maintain its dominance throughout the forecast period due to increasing geriatric population, which is more susceptible to cardiovascular diseases. Moreover, technological advancements coupled with growing healthcare awareness are also contributing toward regional growth.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing rising healthcare expenditure and improving infrastructure in countries such as India and China. In addition, increasing medical tourism in these developing economies will also contribute toward regional growth during the forecast period. Growing investments by international companies for manufacturing advanced devices will further boost demand for this market over the coming years (2018-2030).
Growth Factors:
- Increasing prevalence of structural heart diseases
- Growing demand for minimally invasive procedures
- Technological advancements in structural heart disease treatment devices
- Rising awareness about the benefits of early diagnosis and treatment of structural heart diseases
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Structural Heart Disease Treatment Devices Market Research Report
By Type
Repair Devices, Replacement Devices
By Application
Hospitals, Ambulatory Surgery Centers, Others
By Companies
Abbott, Boston Scientific, Edwards Lifesciences, LivaNova, Lepu Medical Technology, Medtronic, Abbott
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
214
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Structural Heart Disease Treatment Devices Market Report Segments:
The global Structural Heart Disease Treatment Devices market is segmented on the basis of:
Types
Repair Devices, Replacement Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgery Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Boston Scientific
- Edwards Lifesciences
- LivaNova
- Lepu Medical Technology
- Medtronic
- Abbott
Highlights of The Structural Heart Disease Treatment Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Repair Devices
- Replacement Devices
- By Application:
- Hospitals
- Ambulatory Surgery Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Structural Heart Disease Treatment Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Structural heart disease treatment devices are medical devices that are used to help treat structural heart diseases. These devices can help improve the flow of blood and oxygen to the heart, which can improve the patient's overall health.
Some of the major companies in the structural heart disease treatment devices market are Abbott, Boston Scientific, Edwards Lifesciences, LivaNova, Lepu Medical Technology, Medtronic, Abbott.
The structural heart disease treatment devices market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Structural Heart Disease Treatment Devices Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Structural Heart Disease Treatment Devices Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Structural Heart Disease Treatment Devices Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Structural Heart Disease Treatment Devices Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Structural Heart Disease Treatment Devices Market Size & Forecast, 2018-2028 4.5.1 Structural Heart Disease Treatment Devices Market Size and Y-o-Y Growth 4.5.2 Structural Heart Disease Treatment Devices Market Absolute $ Opportunity
Chapter 5 Global Structural Heart Disease Treatment Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Structural Heart Disease Treatment Devices Market Size Forecast by Type
5.2.1 Repair Devices
5.2.2 Replacement Devices
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Structural Heart Disease Treatment Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Structural Heart Disease Treatment Devices Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgery Centers
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Structural Heart Disease Treatment Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Structural Heart Disease Treatment Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Structural Heart Disease Treatment Devices Analysis and Forecast
9.1 Introduction
9.2 North America Structural Heart Disease Treatment Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Structural Heart Disease Treatment Devices Market Size Forecast by Type
9.6.1 Repair Devices
9.6.2 Replacement Devices
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Structural Heart Disease Treatment Devices Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgery Centers
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Structural Heart Disease Treatment Devices Analysis and Forecast
10.1 Introduction
10.2 Europe Structural Heart Disease Treatment Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Structural Heart Disease Treatment Devices Market Size Forecast by Type
10.6.1 Repair Devices
10.6.2 Replacement Devices
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Structural Heart Disease Treatment Devices Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgery Centers
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Structural Heart Disease Treatment Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Structural Heart Disease Treatment Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Structural Heart Disease Treatment Devices Market Size Forecast by Type
11.6.1 Repair Devices
11.6.2 Replacement Devices
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Structural Heart Disease Treatment Devices Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgery Centers
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Structural Heart Disease Treatment Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America Structural Heart Disease Treatment Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Structural Heart Disease Treatment Devices Market Size Forecast by Type
12.6.1 Repair Devices
12.6.2 Replacement Devices
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Structural Heart Disease Treatment Devices Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgery Centers
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Structural Heart Disease Treatment Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Structural Heart Disease Treatment Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Structural Heart Disease Treatment Devices Market Size Forecast by Type
13.6.1 Repair Devices
13.6.2 Replacement Devices
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Structural Heart Disease Treatment Devices Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgery Centers
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Structural Heart Disease Treatment Devices Market: Competitive Dashboard
14.2 Global Structural Heart Disease Treatment Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Boston Scientific
14.3.3 Edwards Lifesciences
14.3.4 LivaNova
14.3.5 Lepu Medical Technology
14.3.6 Medtronic
14.3.7 Abbott